ADRENAL GLAND — STRUCTURE, HORMONES & FUNCTION (LOGIC-BASED MASTER NOTE)
I. BIG PICTURE OVERVIEW
1️⃣ Two endocrine organs in one gland
The adrenal gland contains two embryologically, structurally, and functionally distinct endocrine organs:
Component | Origin | Hormone type | Core role |
Adrenal medulla | Neural crest | Catecholamines | Acute stress (“fight-or-flight”) |
Adrenal cortex | Mesoderm | Steroid hormones | Metabolic, electrolyte, sexual regulation |
II. ADRENAL MEDULLA — LOGIC
2️⃣ Functional identity
- The adrenal medulla is essentially a modified sympathetic ganglion
- Key modification:
- Postganglionic neurons have lost their axons
- They have become secretory cells
- Innervation:
- Preganglionic sympathetic fibers
- Travel via splanchnic nerves
- Release acetylcholine (ACh)
👉 Therefore:
Neural stimulus → hormonal release into blood
3️⃣ Hormones secreted
- Epinephrine (major in humans & dogs)
- Norepinephrine
- Small amounts of dopamine
📌 Purpose:
Prepare the body for emergency responses (fight-or-flight)
III. ADRENAL CORTEX — LOGIC
4️⃣ Hormone classes
Hormone class | Zone | Core function |
Mineralocorticoids | Zona glomerulosa | Na⁺ balance, ECF volume |
Glucocorticoids | Zona fasciculata | Carbohydrate & protein metabolism |
Androgens | Zona reticularis | Secondary sex hormone source |
📌 Glucocorticoids + mineralocorticoids are essential for survival
5️⃣ Control of secretion
- ACTH (anterior pituitary):
- Primary control of glucocorticoids
- Trophic to zona fasciculata & reticularis
- Angiotensin II:
- Primary regulator of aldosterone
- Acts independently of ACTH
IV. ADRENAL MORPHOLOGY — MEDULLA
6️⃣ Structural features
- Forms 28% of adrenal mass
- Cells arranged as:
- Interlacing cords
- Closely apposed to venous sinusoids
- Densely innervated
7️⃣ Medullary cell types
Cell type | Granules | % in humans |
Epinephrine-secreting | Large, less dense | 90% |
Norepinephrine-secreting | Small, very dense | 10% |
❓ Dopamine-secreting cell morphology → unknown
8️⃣ Paraganglia
- Extra-adrenal collections of medullary-like cells
- Located near:
- Thoracic sympathetic ganglia
- Abdominal sympathetic ganglia
V. ADRENAL MORPHOLOGY — CORTEX
9️⃣ Cortical zones (adult)
Zone | Arrangement | % mass | Main secretion |
Zona glomerulosa | Whorls | 15% | Aldosterone |
Zona fasciculata | Columns | 50% | Glucocorticoids |
Zona reticularis | Interlacing network | 7% | Sex hormones |
📌 Cells contain abundant lipid, especially in zona fasciculata.
🔬 Enzymatic specialization
- All zones → secrete corticosterone
- Aldosterone enzymes → only zona glomerulosa
- Cortisol + sex hormone enzymes → inner two zones
- Functional dominance:
- Fasciculata → glucocorticoids
- Reticularis → androgens
VI. ADRENAL BLOOD SUPPLY — EXAM FAVORITE
🔁 Dual supply
- Arterial input:
- Phrenic arteries
- Renal arteries
- Aorta
- Blood flow:
- Capsule plexus → cortex → medullary sinusoids
- PLUS direct arterioles to medulla
- Venous drainage:
- Single central adrenal vein
- Flow is very high (typical endocrine gland feature)
📌 Functional consequence:
Cortical hormones bathe the medulla
VII. FETAL ADRENAL — UNIQUE HUMAN FEATURE
🔹 Structure
- In fetus:
- Adrenal is large
- 80% = fetal cortex
- 20% = permanent cortex
- Fetal cortex:
- Degenerates rapidly after birth
🔹 Function
- Produces sulfated androgens
- Placenta converts them → estrogens
📌 No comparable structure in lab animals
VIII. CORTICAL CELL RENEWAL & PITUITARY EFFECTS
🔁 Regeneration
- Zona glomerulosa:
- Source of new cortical cells
- Removal of fasciculata & reticularis:
- These regenerate from glomerular cells
🚫 Medulla does NOT regenerate
🧠 Hypophysectomy effects
Zone | Effect |
Fasciculata & reticularis | Atrophy |
Glomerulosa | Preserved (Ang II) |
- Aldosterone initially normal
- Long-term hypopituitarism → aldosterone deficiency
- ACTH:
- Hypertrophies inner zones
- Shrinks zona glomerulosa
IX. STEROID-SECRETING CELL ULTRASTRUCTURE
- Smooth endoplasmic reticulum → steroid synthesis
- Mitochondria → key enzymatic steps
- Same structure across all steroid-secreting tissues
🧠 ADRENAL GLAND — COMPLETE LOGIC-BASED MASTER TABLE (ZERO OMISSION)
DOMAIN | ADRENAL MEDULLA | ADRENAL CORTEX (GENERAL) | ZONA GLOMERULOSA | ZONA FASCICULATA | ZONA RETICULARIS | FETAL ADRENAL CORTEX |
Embryological origin | Neural crest | Mesoderm | Mesoderm | Mesoderm | Mesoderm | Mesoderm |
Functional identity | Modified sympathetic ganglion | Steroid-secreting endocrine tissue | Mineralocorticoid zone | Glucocorticoid zone | Androgen zone | Temporary endocrine organ |
Cell nature | Postganglionic neurons without axons → secretory cells | Steroidogenic epithelial cells | Steroidogenic cells | Steroidogenic cells | Steroidogenic cells | Steroidogenic cells |
Main hormone class | Catecholamines | Steroids | Mineralocorticoids | Glucocorticoids | Androgens | Sulfated androgens |
Specific hormones | Epinephrine (major), norepinephrine, dopamine (small) | Corticosterone (all zones) | Aldosterone | Cortisol (± corticosterone) | DHEA, androstenedione | DHEA-S |
Physiological role | Acute stress (fight-or-flight) | Metabolic, electrolyte, sexual regulation | Na⁺ retention, ECF volume | Glucose, protein & fat metabolism | Secondary sex hormone source | Estrogen precursor (via placenta) |
Essential for life | No | Yes | Yes | Yes | No | No |
Primary control | Preganglionic sympathetic (ACh) | ACTH (trophic) + Ang II | Angiotensin II (ACTH minor) | ACTH | ACTH | ACTH (fetal pituitary) |
Innervation | Dense sympathetic (splanchnic nerves) | None | None | None | None | None |
Signal type | Neural → hormonal | Hormonal | Hormonal | Hormonal | Hormonal | Hormonal |
Cell arrangement | Interlacing cords | Layered zones | Whorls | Straight columns | Interlacing network | Broad cords |
% of adrenal mass | ~28% | ~72% | ~15% | ~50% | ~7% | ~80% of fetal gland |
Cytoplasmic lipid | Minimal | Present | Moderate | Abundant | Moderate | Abundant |
Secretory granules | Yes | No | No | No | No | No |
Granule density | Epi: large pale (90%) NE: small dense (10%) | — | — | — | — | — |
Dopamine cells | Present (morphology unknown) | — | — | — | — | — |
Paraganglia equivalent | Yes (extra-adrenal) | No | No | No | No | No |
Blood supply (input) | Cortical blood + direct arterioles | Capsule plexus | Capsule plexus | Capsule plexus | Capsule plexus | Capsule plexus |
Blood flow pattern | Cortex → medulla + direct supply | Very high | → sinusoids | → sinusoids | → sinusoids | → sinusoids |
Functional consequence | Exposed to high cortisol | — | — | — | — | — |
Venous drainage | Single central adrenal vein | Single central adrenal vein | Same | Same | Same | Same |
Regeneration capacity | ❌ Does NOT regenerate | ✅ Regenerates | Stem cell source | Regenerates from glomerulosa | Regenerates from glomerulosa | Degenerates after birth |
Effect of hypophysectomy | No direct effect | Inner cortex atrophies | Preserved initially | Atrophy | Atrophy | Atrophy |
Long-term pituitary loss | — | ↓ steroid output | Aldosterone ↓ late | ↓ cortisol | ↓ androgens | — |
Effect of excess ACTH | — | Cortical hypertrophy | Shrinks | Hypertrophy | Hypertrophy | — |
Postnatal fate | Permanent | Permanent | Permanent | Permanent | Permanent | Rapid involution |
Placental interaction | No | No | No | No | No | Androgens → estrogens |
Ultrastructure | Dense-core granules | SER + mitochondria | SER + mitochondria | SER + mitochondria | SER + mitochondria | SER + mitochondria |
✅ EXAM LOCK (one-line logic summary)
Medulla = neural stress hormones; Cortex = layered steroid factory; Glomerulosa survives without ACTH; Fasciculata & Reticularis die without ACTH; Fetal cortex feeds placenta.
ADRENAL MEDULLA — HORMONES & MECHANISMS
X. CATECHOLAMINES
🔹 Species differences
Species | Main secretion |
Cats | Norepinephrine |
Dogs & humans | Epinephrine |
📌 Norepinephrine also enters blood from sympathetic nerve endings
🔹 Biosynthesis logic
- Tyrosine → DOPA → Dopamine → Norepinephrine → Epinephrine
- PNMT:
- Converts NE → E
- Present mainly in brain & adrenal medulla
- Induced by glucocorticoids
👉 Cortisol-rich blood from cortex → stimulates epinephrine synthesis
🔹 Developmental link
- 21β-hydroxylase deficiency:
- ↓ fetal glucocorticoids
- → medullary dysplasia
- → ↓ catecholamines after birth
XI. PLASMA HANDLING & METABOLISM
🔹 Conjugation
Catecholamine | % sulfate-conjugated |
Dopamine | 95% |
NE & E | 70% |
- Sulfate conjugates = inactive
🔹 Normal plasma levels
Hormone | Level |
Free NE | ~300 pg/mL |
Free E | ~30 pg/mL |
Dopamine | ~0.13 nmol/L |
- Standing → NE ↑ 50–100%
- Adrenalectomy:
- NE unchanged
- E → zero (later low reappearance from unknown source)
🔹 Metabolism
- Half-life ≈ 2 min
- Metabolized to:
- Metanephrine / normetanephrine
- VMA
Daily urinary excretion:
- NE ≈ 30 μg
- E ≈ 6 μg
- VMA ≈ 700 μg
XII. MEDULLARY CO-SECRETED SUBSTANCES
- Stored with:
- ATP
- Chromogranin A
- Secretion mechanism:
- ACh → Ca²⁺ influx → exocytosis
- Also secreted:
- Met-enkephalin (opioid peptide)
- Adrenomedullin (vasodepressor)
📌 Opioids do not cross BBB
XIII. EFFECTS OF EPINEPHRINE & NOREPINEPHRINE
🔹 Receptor classes
- α₁, α₂
- β₁, β₂, β₃
❤️ Cardiovascular
Effect | NE | E |
HR & contractility | ↑ (β₁) | ↑↑ (β₁) |
Vessels | Vasoconstriction (α₁) | Muscle vasodilation (β₂) |
BP | ↑ systolic & diastolic | ↑ pulse pressure |
Reflex bradycardia | Yes | Minimal |
🧠 CNS
- ↑ Alertness
- Epinephrine → more anxiety & fear
🍬 Metabolic
- Glycogenolysis (liver & muscle)
- ↑ FFA
- ↑ Lactate
- ↑ Metabolic rate (biphasic)
- Cold intolerance in catecholamine-deficient mice
🧂 Potassium
- Initial ↑ plasma K⁺
- Sustained ↓ plasma K⁺ (β₂-mediated muscle uptake)
🧪 Threshold plasma levels (epinephrine)
Effect | Level |
Tachycardia | 50 pg/mL |
↑ SBP, lipolysis | 75 pg/mL |
Hyperglycemia, ↓ DBP | 150 pg/mL |
↓ Insulin (α-effect) | 400 pg/mL |
📌 NE rarely reaches systemic threshold → acts mainly locally
🩺 Pheochromocytoma
- Sustained hypertension
- 15% epinephrine-secreting tumors:
- Episodic palpitations
- Headache
- Glycosuria
- Extreme systolic HTN
XIV. EFFECTS OF DOPAMINE
- Physiologic role in circulation → unclear
- Actions:
- Renal vasodilation (dopaminergic receptors)
- Mesenteric vasodilation
- Cardiac inotropy (β₁)
- ↑ SBP, unchanged DBP
- Renal dopamine:
- Causes natriuresis
- Inhibits Na⁺/K⁺-ATPase
- Clinical use:
- Traumatic & cardiogenic shock
🧠 ADRENAL MEDULLA — CATECHOLAMINES (MASTER TABLE SET)
1️⃣ Species Differences in Catecholamine Secretion
Species | Main Catecholamine Secreted |
Cats | Norepinephrine (NE) |
Dogs | Epinephrine (E) |
Humans | Epinephrine (E) |
Exam note:
📌 Norepinephrine also enters circulation from sympathetic nerve endings (not only adrenal medulla).
2️⃣ Biosynthesis of Catecholamines (Logic Table)
Step | Conversion |
1 | Tyrosine → DOPA |
2 | DOPA → Dopamine |
3 | Dopamine → Norepinephrine |
4 | Norepinephrine → Epinephrine |
PNMT (Phenylethanolamine-N-methyltransferase)
Feature | Detail |
Function | Converts NE → E |
Location | Mainly adrenal medulla & brain |
Regulation | Induced by glucocorticoids |
Key logic | Cortisol-rich blood from cortex → medulla stimulates epinephrine synthesis |
3️⃣ Developmental Link — 21β-Hydroxylase Deficiency
Pathology Step | Outcome |
↓ Fetal glucocorticoids | ↓ PNMT induction |
→ Medullary dysplasia | ↓ Epinephrine synthesis |
Post-birth effect | ↓ Catecholamine secretion |
4️⃣ Plasma Handling — Conjugation
Catecholamine | % Sulfate-Conjugated |
Dopamine | 95% |
Norepinephrine | 70% |
Epinephrine | 70% |
📌 Sulfate-conjugated catecholamines are biologically inactive.
5️⃣ Normal Plasma Levels
Hormone | Plasma Level |
Free Norepinephrine | ~300 pg/mL |
Free Epinephrine | ~30 pg/mL |
Dopamine | ~0.13 nmol/L |
Physiologic Modifiers
Situation | Effect |
Standing | NE ↑ 50–100% |
Adrenalectomy | NE unchanged |
Epinephrine → zero | |
Later: low E reappears from unknown source |
6️⃣ Metabolism & Excretion
Feature | Detail |
Plasma half-life | ~2 minutes |
Major metabolites | Metanephrine, Normetanephrine, VMA |
Daily Urinary Excretion
Substance | Amount |
Norepinephrine | ~30 μg/day |
Epinephrine | ~6 μg/day |
VMA | ~700 μg/day |
7️⃣ Medullary Co-Secreted Substances
Stored Together With Catecholamines
Substance | Role |
ATP | Granule stabilization |
Chromogranin A | Storage protein |
Secretion Mechanism
Step | Detail |
Trigger | ACh from preganglionic sympathetic fibers |
Cellular event | Ca²⁺ influx |
Result | Exocytosis |
Other Secreted Substances
Substance | Action |
Met-enkephalin | Opioid peptide |
Adrenomedullin | Vasodepressor (vasodialation) |
📌 Opioid peptides do NOT cross the blood–brain barrier.
8️⃣ Adrenergic Receptors
Receptor Classes
α₁, α₂
β₁, β₂, β₃
9️⃣ Cardiovascular Effects
Effect | Norepinephrine (NE) | Epinephrine (E) |
Heart rate & contractility | ↑ (β₁) | ↑↑ (β₁) |
Blood vessels | Vasoconstriction (α₁) | Muscle vasodilation (β₂) |
Blood pressure | ↑ SBP & DBP | ↑ Pulse pressure |
Reflex bradycardia | Yes | Minimal |
🔟 CNS Effects
Effect | Detail |
Alertness | ↑ |
Emotional response | Epinephrine → more anxiety & fear |
1️⃣1️⃣ Metabolic Effects
Effect | Outcome |
Glycogenolysis | Liver & muscle |
Lipolysis | ↑ Free fatty acids |
Lactate | ↑ |
Metabolic rate | ↑ (biphasic) |
Experimental finding | Catecholamine-deficient mice → cold intolerance |
1️⃣2️⃣ Potassium Effects
Phase | Plasma K⁺ |
Initial | ↑ |
Sustained | ↓ (β₂-mediated muscle uptake) |
1️⃣3️⃣ Threshold Plasma Levels — Epinephrine
Effect | Plasma Level |
Tachycardia | 50 pg/mL |
↑ SBP, lipolysis | 75 pg/mL |
Hyperglycemia, ↓ DBP | 150 pg/mL |
↓ Insulin secretion (α-effect) | 400 pg/mL |
📌 NE rarely reaches systemic threshold → acts mainly locally.
1️⃣4️⃣ Pheochromocytoma
Feature | Detail |
Blood pressure | Sustained hypertension |
Epinephrine-secreting tumors | ~15% |
Episodic symptoms | Palpitations, headache |
Metabolic effect | Glycosuria |
BP pattern | Extreme systolic hypertension |
1️⃣5️⃣ Dopamine — Effects & Clinical Use
Aspect | Detail |
Physiologic role | Unclear |
Renal circulation | Vasodilation (dopaminergic receptors) |
Mesenteric circulation | Vasodilation |
Cardiac effect | ↑ Inotropy (β₁) |
Blood pressure | ↑ SBP, DBP unchanged |
Renal Dopamine Actions
Effect | Mechanism |
Natriuresis | ↓ Na⁺ reabsorption |
Tubular effect | Inhibits Na⁺/K⁺-ATPase |
Clinical Use
Indication
Traumatic shock
Cardiogenic shock
ADRENAL GLAND — REGULATION, STRUCTURE, BIOSYNTHESIS & ENZYME DEFECTS (LOGIC NOTE)
PART A — ADRENAL MEDULLA
Regulation of Adrenal Medullary Secretion
1️⃣ Core Principle
- Adrenal medulla = modified sympathetic ganglion
- Secretion is neural, not hormonal
- Physiologic stimuli → CNS → sympathetic outflow → adrenal medulla
2️⃣ Basal Secretion
- Catecholamine secretion is low at rest
- During sleep:
- Epinephrine ↓
- Norepinephrine ↓ further
👉 Confirms tonic sympathetic dependence
3️⃣ Emergency / Stress Response
- Part of diffuse sympathetic discharge
- Described by Cannon as:
“Emergency function of the sympathoadrenal system”
Situations:
- Fear
- Trauma
- Exercise
- Hypoglycemia
- Cold exposure
4️⃣ Functional Importance of Circulating Catecholamines
Especially important when systemic metabolic support is needed:
A. Cold exposure
- Catecholamines → calorigenic effect
- ↑ heat production
B. Hypoglycemia
- Catecholamines → glycogenolysis
- ↑ blood glucose
5️⃣ Selective Secretion (HIGH-YIELD EXAM LOGIC)
Situation | Predominant Catecholamine |
Familiar emotional stress | ↑ Norepinephrine |
Unfamiliar / unpredictable stress | ↑ Epinephrine |
🔑 Total secretion ↑, but NE:E ratio usually unchanged
PART B — ADRENAL CORTEX
Structure & Classification of Adrenocortical Hormones
6️⃣ Steroid Core Structure
- All adrenal cortical hormones are cholesterol derivatives
- Share cyclopentanoperhydrophenanthrene nucleus
Same family as:
- Gonadal steroids
- Bile acids
- Vitamin D
7️⃣ Steroid Carbon Classification
Class | Carbon Count | Key Feature | Source |
C21 | 21 carbons | 2-carbon side chain at C17 | Adrenal |
C19 | 19 carbons | 17-keto / 17-OH | Adrenal + gonads |
C18 | 18 carbons | No angular methyl at C10 | Ovary |
8️⃣ Functional Classification (Selye)
C21 Steroids
- Mineralocorticoids
- Na⁺ retention
- K⁺ excretion
- Glucocorticoids
- Glucose metabolism
- Protein catabolism
⚠️ All C21 steroids have BOTH activities
→ classification depends on predominant effect
9️⃣ Steroid Configuration Rules (Exam Traps)
- Δ → double bond
- β (solid line) → above plane
- α (dashed) → below plane
Naturally occurring adrenal steroids:
- Δ⁴-3-keto A-ring
- 17-OH → α configuration
- 3, 11, 21-OH → β configuration
- Aldosterone → 18-aldehyde (D-form)
- L-aldosterone = inactive
🔟 Steroids Secreted in Physiologic Amounts
Mineralocorticoid
- Aldosterone
Glucocorticoids
- Cortisol
- Corticosterone
Androgens
- DHEA
- Androstenedione
1️⃣1️⃣ Special Steroid Notes
- Deoxycorticosterone (DOC)
- Secreted ≈ aldosterone
- Only 3% mineralocorticoid potency
- Clinically relevant only when ↑
- Adrenal estrogens
- Derived peripherally from androstenedione
- DHEA
- Secreted mainly as DHEA-S
- Others secreted unconjugated
1️⃣2️⃣ Species Differences (Exam Favorite)
Species | Major Glucocorticoid |
Birds, rats, mice | Corticosterone |
Dogs | Cortisol ≈ Corticosterone |
Humans | Cortisol ≫ corticosterone (7:1) |
PART C — STEROID BIOSYNTHESIS
Pathway Logic
1️⃣3️⃣ Cholesterol Handling
- Source:
- Mostly from LDL uptake
- LDL receptors abundant in adrenal cortex
- Stored as cholesterol esters in lipid droplets
- Cholesterol ester hydrolase → free cholesterol
1️⃣4️⃣ Rate-Limiting Step
- Transport into mitochondria via StAR protein
- Conversion to pregnenolone
- Enzyme:
- Cholesterol desmolase
- P450scc
- CYP11A1
- Location: Mitochondria
1️⃣5️⃣ Smooth ER Reactions
3β-Hydroxysteroid Dehydrogenase
(Not a P450)
Converts:
- Pregnenolone → Progesterone
- 17-OH pregnenolone → 17-OH progesterone
- DHEA → Androstenedione
1️⃣6️⃣ 17α-Hydroxylase / 17,20-Lyase
- CYP17
- Produces:
- 17-OH steroids
- C19 androgens
1️⃣7️⃣ 21β-Hydroxylase
- CYP21A2
- SER enzyme
- Forms:
- 11-deoxycorticosterone
- 11-deoxycortisol
1️⃣8️⃣ Final Mitochondrial Step
11β-Hydroxylase
- CYP11B1
- Converts:
- DOC → Corticosterone
- 11-deoxycortisol → Cortisol
1️⃣9️⃣ Aldosterone Synthase
- CYP11B2
- Present only in zona glomerulosa
- Absent:
- 17α-hydroxylase
- 11β-hydroxylase
👉 Explains aldosterone only
2️⃣0️⃣ Zonal Specialization
Zone | Enzyme Bias | Hormone |
Glomerulosa | CYP11B2 | Aldosterone |
Fasciculata | 3β-HSD | Cortisol |
Reticularis | 17,20-lyase + sulfokinase | DHEA-S |
PART D — REGULATION
ACTH & ANGIOTENSIN II
2️⃣1️⃣ ACTH
- Receptor → Gs
- ↑ adenylyl cyclase → ↑ cAMP
- Immediate: ↑ pregnenolone
- Chronic: ↑ P450 enzyme synthesis
2️⃣2️⃣ Angiotensin II
- Acts on AT1 receptors
- Via PLC → PKC
- Selectively ↑ aldosterone
PART E — ENZYME DEFICIENCIES (CONGENITAL ADRENAL HYPERPLASIA)
2️⃣3️⃣ General Rule
- ↓ Cortisol → ↑ ACTH → adrenal hyperplasia
2️⃣4️⃣ Key Defects
A. Cholesterol desmolase deficiency
- Fatal in utero
- Placenta can’t make progesterone
B. StAR deficiency
- Congenital lipoid adrenal hyperplasia
- ↓ all steroids
- Female external genitalia regardless of genotype
C. 3β-HSD deficiency
- ↑ DHEA
- Mild virilization in females
- Hypospadias in males
D. 17α-Hydroxylase deficiency
- ↓ Sex steroids
- ↑ DOC → hypertension + hypokalemia
- Corticosterone partially compensates cortisol
E. 21β-Hydroxylase deficiency (MOST COMMON – 90%)
- ↓ Cortisol ± aldosterone
- ↑ Androgens → virilization
- 75% = salt-losing
F. 11β-Hydroxylase deficiency
- ↑ DOC → hypertension
- Virilization present
2️⃣5️⃣ Treatment Principle
- Glucocorticoids
- Replace cortisol
- Suppress ACTH
- ↓ androgen excess
2️⃣6️⃣ Transcriptional Control
- Enzyme expression depends on Steroid Factor-1 (SF-1)
- Knockout → no adrenal + gonadal development
PART F — SYNTHETIC STEROIDS (CLINICAL BOX LOGIC)
- Structural modification → ↑ potency
- Dexamethasone
- High receptor affinity
- Long half-life
- Strong glucocorticoid, minimal mineralocorticoid
FINAL EXAM LOCK
- Medulla = neural
- Cortex = steroid + zonal enzyme logic
- ACTH → cortisol
- Ang II → aldosterone
- ↓ cortisol = ↑ ACTH = hyperplasia
- 21β-hydroxylase = most common defect
🧠 ADRENAL GLAND — COMPLETE MASTER TABLES (EXAM-READY)
TABLE 1 — ADRENAL MEDULLA: REGULATION & PHYSIOLOGY
Aspect | Key Points |
Nature | Modified sympathetic ganglion |
Type of control | Neural (NOT hormonal) |
Pathway | Physiologic stimulus → CNS → sympathetic outflow → adrenal medulla |
Neurotransmitter | Acetylcholine from preganglionic fibers |
Hormones secreted | Epinephrine + Norepinephrine |
TABLE 2 — BASAL vs STRESS SECRETION (MEDULLA)
State | Epinephrine | Norepinephrine | Key Logic |
Rest | Low | Low | Tonic sympathetic tone |
Sleep | ↓ | ↓↓ | Confirms neural dependence |
Emergency / stress | ↑↑ | ↑↑ | Diffuse sympathetic discharge |
TABLE 3 — STRESS TYPES & CATECHOLAMINE DOMINANCE (EXAM FAVORITE)
Situation | Predominant Hormone |
Familiar emotional stress | Norepinephrine |
Unfamiliar / unpredictable stress | Epinephrine |
Overall secretion | ↑ total |
NE:E ratio | Usually unchanged |
TABLE 4 — PHYSIOLOGIC IMPORTANCE OF CIRCULATING CATECHOLAMINES
Situation | Effect | Mechanism |
Cold exposure | ↑ Heat production | Calorigenic effect |
Hypoglycemia | ↑ Blood glucose | Glycogenolysis |
🧱 ADRENAL CORTEX
TABLE 5 — STEROID CORE STRUCTURE
Feature | Detail |
Basic nucleus | Cyclo-pentano-perhydro-phenanthrene |
Precursor | Cholesterol |
Same family as | Gonadal steroids, bile acids, vitamin D |
TABLE 6 — STEROID CARBON CLASSIFICATION
Class | Carbon No. | Structural Feature | Source | |
C21 | 21 | 2-carbon side chain at C17 | Adrenal | Aldosteron, Cortisole, Progesteron |
C19 | 19 | 17-keto / 17-OH | Adrenal + gonads | Testosteron, Androstenedion, DHEA |
C18 | 18 | No angular methyl at C10 | Ovary | Estradiol, Estron, Estriol |
TABLE 7 — FUNCTIONAL CLASSIFICATION (SELYE)
Steroid Type | Primary Action |
Mineralocorticoids | Na⁺ retention, K⁺ excretion |
Glucocorticoids | Glucose metabolism, protein catabolism |
Key rule | All C21 steroids have BOTH actions |
Classification basis | Predominant physiologic effect |
TABLE 8 — STEROID CONFIGURATION RULES (EXAM TRAPS)
Feature | Rule |
Δ | Double bond |
β (solid line) | Above plane |
α (dashed line) | Below plane |
A-ring | Δ⁴-3-keto |
17-OH | α-orientation |
3, 11, 21-OH | β-orientation |
Aldosterone | 18-aldehyde (D-form) |
L-aldosterone | Inactive |
TABLE 9 — PHYSIOLOGICALLY SECRETED ADRENAL STEROIDS
Category | Hormones |
Mineralocorticoid | Aldosterone |
Glucocorticoids | Cortisol, Corticosterone |
Androgens | DHEA, Androstenedione |
TABLE 10 — SPECIAL STEROID NOTES
Steroid | Key Points |
Deoxycorticosterone (DOC) | Secreted ≈ aldosterone amount |
Only 3% mineralocorticoid potency | |
Relevant only when ↑ | |
Adrenal estrogens | Peripheral conversion from androstenedione |
DHEA | Mostly secreted as DHEA-S |
Others | Secreted unconjugated |
TABLE 11 — SPECIES DIFFERENCES (HIGH-YIELD)
Species | Major Glucocorticoid |
Birds, rats, mice | Corticosterone |
Dogs | Cortisol ≈ corticosterone |
Humans | Cortisol ≫ corticosterone (7:1) |
⚙️ STEROID BIOSYNTHESIS

TABLE 12 — CHOLESTEROL HANDLING
Step | Detail |
Source | Mostly LDL uptake |
Receptors | Abundant LDL receptors |
Storage | Cholesterol esters in lipid droplets |
Mobilization | Cholesterol ester hydrolase |
TABLE 13 — RATE-LIMITING STEP
Feature | Detail |
Protein | StAR |
Process | Transport into mitochondria |
Enzyme | Cholesterol desmolase |
Also called | P450scc / CYP11A1 |
Product | Pregnenolone |
Location | Mitochondria |
TABLE 14 — SMOOTH ER ENZYMES
Enzyme | Converts |
3β-HSD (not P450) | Pregnenolone → Progesterone |
17-OH pregnenolone → 17-OH progesterone | |
DHEA → Androstenedione |
TABLE 15 — KEY BIOSYNTHETIC ENZYMES
Enzyme | Code | Location | Function |
17α-hydroxylase / 17,20-lyase | CYP17 | SER | 17-OH steroids + C19 androgens |
21β-hydroxylase | CYP21A2 | SER | DOC + 11-deoxycortisol |
11β-hydroxylase | CYP11B1 | Mitochondria | Cortisol + corticosterone |
Aldosterone synthase | CYP11B2 | Mitochondria | Aldosterone |
TABLE 16 — ZONAL SPECIALIZATION
Zone | Enzyme Bias | Hormone |
Glomerulosa | CYP11B2 | Aldosterone |
Fasciculata | 3β-HSD | Cortisol |
Reticularis | 17,20-lyase + sulfokinase | DHEA-S |
🎯 REGULATION
TABLE 17 — ACTH vs ANGIOTENSIN II
Hormone | Receptor | Second Messenger | Effect |
ACTH | Gs | ↑ cAMP | ↑ Pregnenolone (immediate) |
↑ P450 enzymes (chronic) | |||
Angiotensin II | AT1 | PLC → PKC | ↑ Aldosterone |
🧬 CONGENITAL ADRENAL HYPERPLASIA (CAH)
TABLE 18 — GENERAL RULE
Core Logic
↓ Cortisol → ↑ ACTH →
Adrenal hyperplasia
TABLE 19 — ENZYME DEFECTS (ZERO-OMISSION)
Defect | Key Features |
Cholesterol desmolase | Fatal in utero |
Placenta can’t make progesterone | |
StAR deficiency | Congenital lipoid adrenal hyperplasia |
↓ All steroids | |
Female external genitalia in all | |
3β-HSD | ↑ DHEA |
Mild female virilization | |
Hypospadias in males | |
17α-hydroxylase | ↓ Sex steroids |
↑ DOC → HTN + hypokalemia | |
Corticosterone partially replaces cortisol | |
21β-hydroxylase | Most common (90%) |
↓ Cortisol ± aldosterone | |
↑ Androgens → virilization | |
75% salt-losing | |
11β-hydroxylase | ↑ DOC → HTN |
Virilization present |
TABLE 20 — TREATMENT PRINCIPLE
Principle | Effect |
Glucocorticoids | Replace cortisol |
Suppress ACTH | |
↓ Androgen excess |
TABLE 21 — TRANSCRIPTIONAL CONTROL
Factor | Role |
Steroid Factor-1 (SF-1) | Regulates enzyme expression |
Knockout | No adrenal + gonadal development |
💊 SYNTHETIC STEROIDS
TABLE 22 — DEXAMETHASONE (CLINICAL LOGIC)
Feature | Detail |
Receptor affinity | Very high |
Half-life | Long |
Glucocorticoid effect | Strong |
Mineralocorticoid effect | Minimal |
🔐 FINAL EXAM LOCK TABLE
Concept | One-Line Lock |
Medulla | Neural control |
Cortex | Steroid + zonal enzymes |
ACTH | Cortisol |
Ang II | Aldosterone |
↓ Cortisol | ↑ ACTH → hyperplasia |
Most common CAH | 21β-hydroxylase deficiency |
TRANSPORT, METABOLISM & EXCRETION OF ADRENOCORTICAL HORMONES
(Logic-Based Core Note — Zero Omission)
I. TRANSPORT IN BLOOD: WHY BINDING MATTERS
1️⃣ Glucocorticoid binding proteins
- Cortisol circulates mainly bound to:
- CBG (corticosteroid-binding globulin)
- Also called transcortin
- An α-globulin
- Albumin → minor contribution
- Corticosterone:
- Binds similarly but less tightly than cortisol
2️⃣ Functional consequences of binding
- Protein-bound steroid = physiologically inactive
- Only free hormone:
- Enters tissues
- Produces biological effects
- Regulates ACTH feedback
- Because most cortisol is bound:
- Very little free cortisol or corticosterone appears in urine
3️⃣ Half-life differences explained by binding
- Cortisol
- Stronger binding → longer half-life
- ≈ 60–90 minutes
- Corticosterone
- Weaker binding → shorter half-life
- ≈ 50 minutes
4️⃣ CBG as a circulating hormone reservoir (KEY CONCEPT)
- Bound cortisol acts as a buffered storage pool
- Maintains a steady free cortisol supply to tissues
- Analogy:
- Same principle as T4 bound to thyroxine-binding proteins
- Prevents rapid fluctuations in hormone action
5️⃣ Saturation of CBG: when free cortisol rises sharply
- Normal total plasma cortisol
- ≈ 13.5 μg/dL (375 nmol/L)
- → Very little is free
- CBG saturation point
- ≈ 20 μg/dL
- Beyond this:
- CBG binding sites are full
- Albumin binding increases slightly
- Major increase occurs in free cortisol fraction
6️⃣ Regulation of CBG synthesis
- Synthesized in the liver
- Estrogen increases CBG production
Clinical states affecting CBG:
Condition | CBG Level |
Pregnancy | ↑ Increased |
Cirrhosis | ↓ Decreased |
Nephrotic syndrome | ↓ Decreased |
Multiple myeloma | ↓ Decreased |
7️⃣ ACTH feedback adaptation to CBG changes
When CBG increases (eg pregnancy):
- More cortisol becomes bound
- Free cortisol initially falls
- ↓ Free cortisol → ↑ ACTH
- ACTH stimulates more cortisol secretion
- New steady state:
- High total cortisol
- Normal free cortisol
- No Cushingoid features
When CBG decreases (eg nephrosis):
- Less cortisol binding
- Total cortisol falls
- Free cortisol remains normal
- No adrenal insufficiency symptoms
📌 Explains key clinical paradox:
- Pregnancy → high total cortisol, no excess
- Nephrosis → low total cortisol, no deficiency
II. METABOLISM & EXCRETION OF GLUCOCORTICOIDS
1️⃣ Primary site of metabolism
- Liver = main site of glucocorticoid catabolism
2️⃣ Major metabolic pathway of cortisol
- Cortisol
- → Dihydrocortisol
- → Tetrahydrocortisol
- → Glucuronide conjugation
- Via glucuronyl transferase
- → Water-soluble metabolite
3️⃣ Glucuronyl transferase system — broader role
- Same enzyme system conjugates:
- Bilirubin
- Other steroid hormones
- Many drugs
- Competitive inhibition occurs among substrates
- High levels of one can slow metabolism of others
4️⃣ 11β-Hydroxysteroid dehydrogenase (11β-HSD)
Two isoenzymes with distinct roles:
🔹 Type 1 (11β-HSD1)
- Bidirectional enzyme
- Converts:
- Cortisol ⇄ cortisone
- Predominant action:
- Reductase
- Generates active cortisol
🔹 Type 2 (11β-HSD2)
- Unidirectional
- Converts:
- Cortisol → cortisone
- Protects mineralocorticoid receptors from cortisol
5️⃣ Cortisone — key clarifications
- Active glucocorticoid (after conversion to cortisol)
- Widely used therapeutically
- Not secreted significantly by adrenal cortex
- Cortisone formed in liver:
- Is rapidly reduced
- Conjugated to tetrahydrocortisone glucuronide
- Does not re-enter circulation in free form
6️⃣ Final excretion of glucocorticoids
- Tetrahydro-glucuronide conjugates:
- Freely water soluble
- Do NOT bind plasma proteins
- Rapidly excreted in urine
7️⃣ Minor metabolic pathways
- ≈ 10% of cortisol
- Converted to 17-ketosteroids
- Via side-chain cleavage in liver
- These are:
- Mostly sulfate-conjugated
- Excreted in urine
- Additional metabolites:
- 20-hydroxy derivatives
- Enterohepatic circulation present
- ≈ 15% of secreted cortisol
- Excreted in stool
8️⃣ Corticosterone metabolism
- Follows same pathways as cortisol
- Key exception:
- Does NOT form 17-ketosteroid derivatives
III. ALDOSTERONE: DISTINCT HANDLING
1️⃣ Transport characteristics
- Minimal protein binding
- Short half-life ≈ 20 minutes
2️⃣ Plasma concentration (comparison)
- Aldosterone:
- ≈ 0.006 μg/dL (0.17 nmol/L)
- Cortisol:
- ≈ 13.5 μg/dL (375 nmol/L)
- Aldosterone secretion is much smaller
3️⃣ Metabolism of aldosterone
- Liver converts much of it to:
- Tetrahydroglucuronide
- Liver + kidney also form:
- 18-glucuronide
4️⃣ Acid-labile conjugate (HIGH-YIELD)
- 18-glucuronide:
- Hydrolyzed to free aldosterone at pH 1.0
- Therefore called acid-labile conjugate
- Unique among steroid metabolites
5️⃣ Urinary excretion pattern
Form | % of secreted aldosterone |
Free aldosterone | < 1% |
Acid-labile conjugate | ≈ 5% |
Tetrahydroglucuronide | Up to 40% |
IV. 17-KETOSTEROIDS
1️⃣ Sources
- Major adrenal androgen:
- Dehydroepiandrosterone (DHEA)
- Also secreted:
- Androstenedione
- Additional contributors:
- Cortisol & cortisone metabolites
- Testosterone metabolism
2️⃣ 11-oxy-17-ketosteroids
- Only steroids with 11-OH or =O at C-11:
- 11-hydroxy-androstenedione
- Cortisol & cortisone metabolites
- Formed in liver via side-chain cleavage
3️⃣ Daily urinary excretion
- Men: ≈ 15 mg/day
- Women: ≈ 10 mg/day
Origin in men:
- ≈ ⅔ adrenal-derived
- ≈ ⅓ testicular
4️⃣ Etiocholanolone — clinical relevance
- Metabolite of:
- Adrenal androgens
- Testosterone
- When unconjugated:
- Causes fever
- Some individuals develop:
- Etiocholanolone fever
- Due to episodic accumulation in blood
V. VARIATIONS IN HEPATIC METABOLISM (CLINICAL BOX)
- Hepatic inactivation of glucocorticoids is reduced in:
- Liver disease
- Surgery
- Stress
- Result:
- Free cortisol rises higher
- Even more than with maximal ACTH alone
- Explains exaggerated cortisol responses during stress

🟩 TABLE 1 — TRANSPORT OF ADRENOCORTICAL HORMONES (CORE LOGIC)
Feature | Cortisol | Corticosterone | Aldosterone |
Main binding protein | CBG (transcortin) + albumin (minor) | CBG (weaker binding) | Minimal binding |
Protein-bound fraction | Very high | High but less than cortisol | Very low |
Free (active) fraction | Very small | Slightly more than cortisol | Relatively high |
Physiologically active form | Free hormone only | Free hormone only | Free hormone |
Urinary free hormone | Very little | Very little | <1% |
Half-life | 60–90 min | ~50 min | ~20 min |
Reason for half-life | Strong CBG binding | Weaker CBG binding | Minimal binding |
Reservoir function | Yes (CBG buffer) | Less effective | None |
🟩 TABLE 2 — CBG (TRANSCORTIN): PROPERTIES & REGULATION
Aspect | Detail |
Protein type | α-globulin |
Site of synthesis | Liver |
Hormones bound | Cortisol > corticosterone |
Function | Buffering reservoir → stabilizes free cortisol |
Analogy | Similar to T4–thyroxine binding proteins |
Estrogen effect | ↑ CBG synthesis |
Effect of saturation | Sharp rise in free cortisol |
🟩 TABLE 3 — CBG SATURATION & PLASMA CORTISOL DYNAMICS
Parameter | Value / Effect |
Normal total cortisol | ≈ 13.5 μg/dL (375 nmol/L) |
Free fraction at normal levels | Very small |
CBG saturation threshold | ≈ 20 μg/dL |
Beyond saturation | Albumin binding ↑ slightly |
Key change | Major rise in free cortisol |
🟩 TABLE 4 — CLINICAL STATES AFFECTING CBG
Condition | CBG Level | Total Cortisol | Free Cortisol | Clinical Effect |
Pregnancy | ↑ | ↑↑ | Normal | No Cushingoid features |
Cirrhosis | ↓ | ↓ | Normal | No adrenal insufficiency |
Nephrotic syndrome | ↓ | ↓ | Normal | No deficiency |
Multiple myeloma | ↓ | ↓ | Normal | No deficiency |
🟩 TABLE 5 — ACTH FEEDBACK ADAPTATION (EXAM PARADOX)
Scenario | Sequence | Final State |
↑ CBG (pregnancy) | ↑ Binding → ↓ free cortisol → ↑ ACTH → ↑ cortisol secretion | ↑ total cortisol, normal free cortisol |
↓ CBG (nephrosis) | ↓ binding → ↓ total cortisol | Free cortisol normal |
Key exam line | Total cortisol ≠ biological effect | Free cortisol matters |
🟩 TABLE 6 — GLUCOCORTICOID METABOLISM: MAJOR PATHWAY
Step | Process |
Primary site | Liver |
Cortisol → | Dihydrocortisol |
→ | Tetrahydrocortisol |
Conjugation | Glucuronide conjugation |
Enzyme | Glucuronyl transferase |
Result | Water-soluble metabolite |
Final excretion | Urine |
🟩 TABLE 7 — GLUCURONYL TRANSFERASE: SYSTEMIC ROLE
Feature | Detail |
Substrates | Cortisol, bilirubin, other steroids, many drugs |
Mechanism | Conjugation → ↑ solubility |
Interaction | Competitive inhibition |
Clinical implication | High substrate load slows metabolism of others |
🟩 TABLE 8 — 11β-HYDROXYSTEROID DEHYDROGENASE (11β-HSD)
Feature | 11β-HSD1 | 11β-HSD2 |
Direction | Bidirectional | Unidirectional |
Main action | Reductase | Oxidase |
Conversion | Cortisone ⇄ cortisol | Cortisol → cortisone |
Functional role | Generates active cortisol | Protects mineralocorticoid receptor |
Key site implication | Liver, adipose | Kidney, placenta |
🟩 TABLE 9 — CORTISONE: EXAM CLARIFICATIONS
Aspect | Detail |
Secreted by adrenal | No (minimal) |
Activity | Active after conversion to cortisol |
Therapeutic use | Common |
Hepatic fate | Rapid reduction + glucuronidation |
Circulation | Does not re-enter as free hormone |
Final metabolite | Tetrahydrocortisone glucuronide |
🟩 TABLE 10 — MINOR METABOLIC PATHWAYS OF CORTISOL
Pathway | Proportion | Notes |
17-ketosteroid formation | ~10% | Via side-chain cleavage |
Conjugation | Mostly sulfate | Urinary excretion |
Other metabolites | 20-hydroxy derivatives | Minor |
Enterohepatic circulation | Present | — |
Fecal excretion | ~15% | Stool |
🟩 TABLE 11 — CORTICOSTERONE METABOLISM
Feature | Detail |
Pathway | Same as cortisol |
Key exception | No 17-ketosteroid formation |
🟩 TABLE 12 — ALDOSTERONE: TRANSPORT & METABOLISM (HIGH-YIELD)
Feature | Aldosterone |
Protein binding | Minimal |
Half-life | ~20 minutes |
Plasma concentration | 0.006 μg/dL (0.17 nmol/L) |
Secretion rate | Very small vs cortisol |
Main metabolism | Liver |
Major conjugate | Tetrahydroglucuronide |
Additional conjugate | 18-glucuronide |
🟩 TABLE 13 — ACID-LABILE CONJUGATE (EXAM GOLD)
Feature | Detail |
Compound | 18-glucuronide |
Hydrolysis | At pH 1.0 |
Result | Free aldosterone |
Term | Acid-labile conjugate |
Uniqueness | Unique among steroid metabolites |
🟩 TABLE 14 — URINARY EXCRETION OF ALDOSTERONE
Form | % of Secreted Aldosterone |
Free aldosterone | <1% |
Acid-labile conjugate | ~5% |
Tetrahydroglucuronide | Up to 40% |
🟩 TABLE 15 — 17-KETOSTEROIDS: SOURCES & EXCRETION
Aspect | Detail |
Major adrenal source | DHEA |
Other contributors | Androstenedione |
Additional sources | Cortisol, cortisone, testosterone metabolism |
Daily excretion (men) | ~15 mg/day |
Daily excretion (women) | ~10 mg/day |
Male origin | ⅔ adrenal, ⅓ testicular |
🟩 TABLE 16 — 11-OXY-17-KETOSTEROIDS
Feature | Detail |
Definition | Steroids with 11-OH or =O at C-11 |
Examples | 11-hydroxyandrostenedione, cortisol metabolites |
Site of formation | Liver |
Mechanism | Side-chain cleavage |
🟩 TABLE 17 — ETIOCHOLANOLONE (CLINICAL PEARL)
Feature | Detail |
Origin | Adrenal androgens + testosterone |
Pathology | Fever when unconjugated |
Syndrome | Etiocholanolone fever |
Mechanism | Episodic accumulation in blood |
🟩 TABLE 18 — VARIATIONS IN HEPATIC METABOLISM (CLINICAL BOX)
Condition | Effect on Metabolism | Result |
Liver disease | ↓ Inactivation | ↑ Free cortisol |
Surgery | ↓ Inactivation | Exaggerated cortisol rise |
Stress | ↓ Inactivation | Cortisol ↑ beyond ACTH effect |
EFFECTS OF ADRENAL ANDROGENS, ESTROGENS & GLUCOCORTICOIDS
(Logic-Based | Zero Omission | Re-audited)
I. ADRENAL ANDROGENS — CORE LOGIC
1. What adrenal androgens are
- Androgens = hormones with masculinizing effects
- Also promote protein anabolism and growth
- Testosterone (from testes) = most potent androgen
- Adrenal androgens:
- Have < 20% of testosterone’s androgenic activity
2. Control of adrenal androgen secretion
- Acute control:
- Regulated by ACTH
- NOT regulated by gonadotropins (LH/FSH)
- Long-term pattern (DHEAS):
- Plasma DHEAS rises gradually
- Peaks in early 20s (~225 μg/dL)
- Declines progressively to very low levels in old age
- Important insight:
- These long-term changes are NOT due to ACTH
- Caused by:
- Increase → then gradual decrease in 17α-hydroxylase lyase activity
3. Circulating form
- DHEA is mostly inactive unless converted
- ~99.7% of DHEA is sulfated
- Circulates as DHEAS
- Only ~0.3% is free DHEA
4. Physiologic androgenic impact
- Adrenal androgen secretion:
- Nearly equal in:
- Castrated males
- Females
- Normal males
- Therefore:
- Minimal masculinization at normal levels
5. Effects of excess adrenal androgens
- Adult males:
- Only accentuate existing male traits
- Prepubertal boys:
- Cause precocious pseudopuberty
- Secondary sex characteristics develop
- NO testicular enlargement
- Females:
- Cause:
- Female pseudohermaphroditism
- Adrenogenital syndrome
6. DHEA supplementation
- DHEA injections promoted by some for “anti-aging”
- Evidence:
- Results controversial
- No consistent proven benefit
II. ADRENAL ESTROGENS — LOGIC
1. Source
- Adrenal androstenedione:
- Converted in peripheral tissues (fat, others) to:
- Testosterone
- Estrogens (via aromatization)
2. Clinical importance
- Major estrogen source in:
- Men
- Postmenopausal women
III. ADRENAL INSUFFICIENCY — PHYSIOLOGIC FAILURE
1. Consequences without treatment
- Mineralocorticoid deficiency:
- Na⁺ loss
- Hypovolemia
- Shock
- Glucocorticoid deficiency:
- Abnormal metabolism of:
- Water
- Carbohydrates
- Proteins
- Fats
- Result:
- Fatal, even if mineralocorticoids alone are given
2. Role of glucocorticoids
- Small amounts:
- Correct metabolic abnormalities
- Act:
- Directly
- Permissively (allow other hormones to work)
IV. MECHANISM OF ACTION — GLUCOCORTICOIDS
1. Genomic actions
- Bind to glucocorticoid receptors
- Steroid-receptor complex:
- Acts as a transcription factor
- Alters gene transcription
- Leads to enzyme synthesis → altered cell function
2. Nongenomic actions
- Evidence suggests rapid, non-DNA mediated effects also exist
V. EFFECTS ON INTERMEDIARY METABOLISM
1. Carbohydrate metabolism
- ↑ Hepatic:
- Glycogenesis
- Gluconeogenesis
- ↑ Glucose-6-phosphatase
- ↑ Plasma glucose
- Peripheral anti-insulin effect
2. Protein metabolism
- ↑ Protein catabolism
- Amino acids → gluconeogenesis
3. Fat metabolism
- In diabetics:
- ↑ Lipolysis
- ↑ Ketone bodies
- In normal individuals:
- Insulin rise masks these effects
4. Organ protection
- Brain & heart:
- Spared from insulin antagonism
- Elevated glucose:
- Ensures supply to vital organs
5. Adrenal insufficiency & fasting
- Fed state:
- Plasma glucose normal
- Fasting:
- Severe hypoglycemia
- Can be fatal
- Adrenal cortex:
- Not essential for ketosis during fasting
VI. PERMISSIVE ACTION — KEY CONCEPT
Definition
- Glucocorticoids do not cause reactions
- But must be present for other hormones to act
Examples
- Required for:
- Glucagon & catecholamine calorigenic effects
- Catecholamine-induced lipolysis
- Catecholamine pressor responses
- Catecholamine bronchodilation
VII. EFFECT ON ACTH SECRETION
- Glucocorticoids:
- Inhibit ACTH secretion (negative feedback)
- Adrenalectomy:
- ↑ ACTH secretion
VIII. VASCULAR REACTIVITY
In adrenal insufficiency
- Vascular smooth muscle:
- Unresponsive to NE & epinephrine
- Capillary dilation
- ↑ Capillary permeability
- Failure of vascular compensation → collapse
Role of glucocorticoids
- Restore responsiveness to catecholamines
- Maintain vascular tone
IX. EFFECTS ON NERVOUS SYSTEM
In adrenal insufficiency
- EEG:
- Slower than normal β rhythm
- Personality changes:
- Irritability
- Apprehension
- Poor concentration
- Reversed only by glucocorticoids
X. WATER METABOLISM
Defect in adrenal insufficiency
- Cannot excrete water load
- Risk of water intoxication
Glucose fever
- Glucose infusion → fever → collapse → death
- Mechanism:
- Water dilutes plasma
- Hypothalamic cell swelling
- Thermoregulatory failure
Mechanisms involved
- ↑ Plasma vasopressin
- ↓ GFR
- Mineralocorticoids:
- Improve volume
- Glucocorticoids:
- Raise GFR more effectively
XI. BLOOD CELLS & LYMPHATIC ORGANS
Effects on circulating cells
- ↓ Eosinophils (sequestration)
- ↓ Basophils
- ↑ Neutrophils
- ↑ Platelets
- ↑ RBCs
Effects on lymphoid tissue
- ↓ Lymphocyte count
- ↓ Lymph node & thymus size
- Mechanism:
- ↓ Mitotic activity
- ↓ IL-2 (via NF-κB inhibition)
- ↑ Lymphocyte apoptosis
XII. RESISTANCE TO STRESS
Definition of stress
- Any threat to homeostasis
ACTH & survival
- Severe stress → ↑ ACTH → ↑ glucocorticoids
- Hypophysectomy or adrenalectomy:
- Animals die under stress
Why glucocorticoids are essential (partially understood)
- Maintain vascular reactivity
- Enable catecholamine-induced FFA mobilization
- Prevent excessive stress responses
Long-term excess
- Chronic ACTH elevation:
- Harmful
- Leads to Cushing syndrome
XIII. CUSHING SYNDROME — PATHOLOGIC EXCESS
1. Definition
- Clinical state of chronic glucocorticoid excess
2. ACTH-independent causes
- Adrenal tumors
- Adrenal hyperplasia
- Prolonged exogenous steroids
- Abnormal receptor expression:
- GIP
- Vasopressin
- β-adrenergic agonists
- IL-1
- GnRH
3. ACTH-dependent causes
- Pituitary adenomas (Cushing disease)
- Ectopic ACTH secretion (lung tumors)
- CRH-secreting tumors
4. Protein catabolism effects
- Thin skin
- Muscle wasting
- Poor wound healing
- Easy bruising
- Thin hair
- Acne & facial hair (from adrenal androgens)
5. Fat redistribution
- Thin limbs
- Central obesity
- Moon face
- Buffalo hump
- Purple striae (dermal rupture)
6. Metabolic effects
- Hyperglycemia
- Insulin-resistant diabetes
- Hyperlipidemia
- Ketosis (usually no severe acidosis)
7. Mineralocorticoid effects
- Salt & water retention
- K⁺ loss
- Weakness
- Hypertension (~85%)
8. Bone effects
- ↓ Bone formation
- ↑ Bone resorption
- Osteoporosis
- Vertebral collapse
9. CNS effects
- EEG acceleration
- Mood changes → psychosis possible
XIV. ANTI-INFLAMMATORY & ANTI-ALLERGIC ACTIONS
Mechanisms
- NF-κB inhibition
- ↓ Cytokine production
- Inhibition of phospholipase A₂
- ↓ Prostaglandins, leukotrienes, thromboxanes
Clinical danger
- Mask infection symptoms
- Without antibiotics → infection spreads
- Sudden steroid withdrawal:
- Severe adrenal insufficiency
XV. OTHER EFFECTS
- ↓ Growth & GH secretion
- ↓ TSH secretion
- ↑ PNMT
- Fetal lung surfactant maturation
XVI. REGULATION OF GLUCOCORTICOID SECRETION
Role of ACTH
- Essential for:
- Basal secretion
- Stress-induced secretion
- Angiotensin II:
- Minor effect (aldosterone)
ACTH chemistry
- 39-aa polypeptide
- Derived from POMC
- First 23 aa = active core
- Half-life ≈ 10 min
Effect on adrenal
- Output ↑ within minutes
- Dose-response:
- Log-linear at low doses
- Ceiling effect at max output
Adrenal responsiveness
- Chronic ACTH:
- ↑ sensitivity
- ACTH suppression:
- ↓ responsiveness
- Detectable within 24 h
Circadian rhythm
- ACTH bursts
- 75% cortisol between 4–10 AM
- Controlled by suprachiasmatic nucleus
Stress response
- Severe stress → ACTH exceeds max needed
- CRH from hypothalamus is main driver
Feedback
- Free cortisol:
- Inhibits ACTH (pituitary + hypothalamus)
- Sudden steroid withdrawal:
- Dangerous
- Requires gradual tapering
Perfect — I’ll compress everything into a small number of master tables so you get maximum integration + zero omission, without fragmenting logic.
Below tables together cover every single point you listed.
🧠 MASTER TABLE 1 — Adrenal Androgens & Estrogens (Source → Control → Effects → Clinical)
Domain | Adrenal Androgens | Adrenal Estrogens |
Main hormones | DHEA, DHEAS, androstenedione | Estrone, estradiol (peripheral conversion) |
Intrinsic potency | <20% of testosterone | Weak unless peripherally converted |
Primary source | Zona reticularis | Peripheral tissues (fat, muscle, skin) |
Circulating form | ~99.7% as DHEAS, ~0.3% free DHEA | Formed locally in tissues |
Activation | Requires peripheral conversion | Aromatization of androstenedione |
Acute control | ACTH dependent | Indirect (substrate availability) |
Not regulated by | LH / FSH | Gonadotropins |
Age-related pattern | Rises → peaks early 20s (~225 μg/dL) → declines | Becomes dominant estrogen source after menopause |
Mechanism of age change | ↑ then ↓ 17α-hydroxylase lyase activity | ↑ relative importance as gonadal estrogen falls |
Physiologic role | Minimal masculinization at normal levels | Major estrogen source in men & postmenopausal women |
Normal secretion equality | Equal in males, females, castrated males | — |
Excess effects – adult male | Accentuation of male traits | — |
Excess effects – prepubertal boy | Precocious pseudopuberty (no testicular growth) | — |
Excess effects – female | Adrenogenital syndrome, pseudohermaphroditism | Virilization via androgen excess |
Supplementation | DHEA injections (anti-aging claims) | — |
Evidence | Controversial, no proven benefit | — |
⚙️ MASTER TABLE 2 — Glucocorticoids: Mechanism of Action
Aspect | Details |
Hormone type | Steroid hormones |
Receptor | Intracellular glucocorticoid receptor |
Primary mechanism | Genomic (DNA-mediated) |
Genomic action | Steroid–receptor complex → transcription factor |
Result | New enzyme synthesis → altered cell function |
Nongenomic actions | Rapid, membrane/second-messenger mediated (evidence exists) |
Feedback | Inhibits ACTH secretion |
Withdrawal | Sudden withdrawal → adrenal crisis |
🔥 MASTER TABLE 3 — Effects on Intermediary Metabolism
Metabolic Domain | Effects |
Carbohydrates | ↑ Gluconeogenesis, ↑ glycogenesis, ↑ G-6-phosphatase, ↑ plasma glucose, peripheral anti-insulin effect |
Proteins | ↑ Protein catabolism → amino acids for gluconeogenesis |
Fats (diabetics) | ↑ Lipolysis, ↑ ketone bodies |
Fats (normal) | Insulin rise masks lipolysis |
Organ protection | Brain & heart spared from insulin antagonism |
Fasting without cortex | Severe hypoglycemia → fatal |
Ketosis | Adrenal cortex not essential for ketosis |
🧩 MASTER TABLE 4 — Permissive Actions of Glucocorticoids (Exam Favorite)
Target Hormone | Effect Enabled by Glucocorticoids |
Catecholamines | Pressor response |
Catecholamines | Lipolysis |
Catecholamines | Bronchodilation |
Glucagon | Calorigenic effects |
Stress hormones | Survival response |
🩸 MASTER TABLE 5 — Vascular, Nervous System & Water Balance Effects
System | Adrenal Insufficiency | Role of Glucocorticoids |
Vessels | Unresponsive to NE/E, capillary dilation, permeability ↑ | Restore vascular tone & responsiveness |
Shock | Failure of compensation → collapse | Prevent collapse |
EEG | Slowed β rhythm | Normalizes EEG |
Personality | Irritability, poor concentration | Reversal |
Water excretion | Cannot excrete water → intoxication | ↑ GFR |
Glucose fever | Water dilution → hypothalamic swelling → death | Prevents |
Vasopressin | Elevated | Normalizes |
GFR | Low | Raised (more than mineralocorticoids) |
🧬 MASTER TABLE 6 — Blood Cells & Lymphoid Tissue
Component | Effect |
Neutrophils | ↑ |
Platelets | ↑ |
RBCs | ↑ |
Eosinophils | ↓ (sequestration) |
Basophils | ↓ |
Lymphocytes | ↓ |
Lymph nodes | Shrink |
Thymus | Shrinks |
Mechanism | ↓ mitosis, ↓ IL-2 (NF-κB inhibition), ↑ apoptosis |
⚠️ MASTER TABLE 7 — Adrenal Insufficiency vs Excess (Cushing Syndrome)
Feature | Adrenal Insufficiency | Cushing Syndrome |
Cortisol | Low | High (chronic) |
Vascular tone | Poor | Maintained |
Glucose | Hypoglycemia (fasting) | Hyperglycemia |
Fat | Normal | Central obesity |
Muscle | Weakness | Wasting |
Skin | Normal | Thin, bruising, striae |
Bone | Normal | Osteoporosis |
BP | Low | Hypertension (~85%) |
CNS | Slow EEG | Accelerated EEG, psychosis possible |
🧠 MASTER TABLE 8 — Cushing Syndrome: Causes & Effects
Category | Details |
ACTH-independent | Adrenal tumors, hyperplasia, exogenous steroids, aberrant receptors (GIP, vasopressin, β-agonists, IL-1, GnRH) |
ACTH-dependent | Pituitary adenoma (Cushing disease), ectopic ACTH, CRH tumors |
Protein effects | Thin skin, muscle wasting, poor healing, acne, hirsutism |
Fat redistribution | Moon face, buffalo hump, truncal obesity |
Metabolic | Diabetes, hyperlipidemia, ketosis |
Mineralocorticoid | Na⁺ retention, K⁺ loss, hypertension |
Bone | ↓ formation, ↑ resorption, fractures |
🧯 MASTER TABLE 9 — Anti-Inflammatory & Other Actions
Domain | Effect |
NF-κB | Inhibited |
Cytokines | ↓ |
PLA₂ | Inhibited |
Eicosanoids | ↓ prostaglandins, leukotrienes, thromboxanes |
Infection risk | Masked symptoms |
Growth | ↓ GH |
Thyroid | ↓ TSH |
Medulla | ↑ PNMT |
Fetus | Lung surfactant maturation |
⏰ MASTER TABLE 10 — Regulation of Glucocorticoid Secretion
Aspect | Details |
Primary regulator | ACTH |
ACTH source | POMC (39 aa peptide) |
Active core | First 23 aa |
Half-life | ~10 minutes |
Response time | Minutes |
Dose–response | Log-linear → ceiling |
Chronic ACTH | ↑ adrenal sensitivity |
Suppression | ↓ responsiveness (within 24 h) |
Circadian rhythm | 75% cortisol 4–10 AM |
Control center | Suprachiasmatic nucleus |
Stress | CRH-driven ACTH surge |
Feedback | Free cortisol inhibits ACTH |
Withdrawal | Must taper slowly |
Mineralocorticoids (Aldosterone) — Effects + Mechanisms + Receptor Logic (Zero-Omission)
1) Core actions (what mineralocorticoids DO)
- Main effect: ↑ Na⁺ reabsorption (so ↓ Na⁺ excretion).
- Sites where Na⁺ reabsorption is increased:
- Urine (kidney)
- Sweat
- Saliva
- Colon contents
- Net body effect: Na⁺ retained in ECF → ECF volume expands.
- Kidney target cell: mainly principal cells (P cells) of the collecting ducts.
- Exchange pattern in renal tubules (functional description):
- Under aldosterone, more Na⁺ is “exchanged” for K⁺ and H⁺
- → ↑ K⁺ loss in urine (K⁺ diuresis / kaliuresis)
- → ↑ H⁺ secretion → urine becomes more acidic (↑ urine acidity)
2) Genomic mechanism (classic steroid pathway) — the “10–30 min onward” effect
A) Receptor → nucleus → gene transcription
- Aldosterone binds a cytoplasmic receptor.
- The hormone–receptor complex moves to the nucleus.
- It changes transcription of mRNAs.
- New mRNAs → new proteins → altered cell function.
B) What the aldosterone-stimulated proteins do (2 time scales)
1) Rapid genomic-associated effect (early):
- ↑ activity of ENaC (epithelial sodium channels) by:
- increasing insertion of ENaCs into the apical membrane
- from a pre-existing cytoplasmic pool of channels
2) Slower effect (later):
- ↑ synthesis of ENaCs (more channel production overall)
C) Specific gene highlighted: SGK
- Aldosterone activates gene for serum- and glucocorticoid-regulated kinase (SGK):
- Serine-threonine protein kinase
- An early response gene
- SGK increases ENaC activity (functional upregulation)
D) ENaC subunits transcription
- Aldosterone increases mRNAs for the 3 ENaC subunits (so more channel components made).
E) Why glucocorticoids activating SGK isn’t a “problem”
- SGK can be activated by glucocorticoids too,
- but at mineralocorticoid receptor (MR) sites, glucocorticoids are inactivated locally (details in section 4), so they don’t normally “take over” MR effects.
F) Important nuance: mechanism not fully “settled”
- Aldosterone activates genes for proteins other than SGK and ENaCs
- and inhibits some genes too.
- Therefore, the exact full chain of how aldosterone-induced proteins produce ↑ Na⁺ reabsorption is still not completely resolved.
G) Timing clue supports genomic dominance
- Principal aldosterone effect on Na⁺ transport:
- starts developing in ~10–30 minutes
- peaks later
- This delay pattern strongly suggests dependence on new protein synthesis via genomic mechanisms.
3) Nongenomic / membrane-initiated rapid action (additional evidence)
- Evidence suggests aldosterone can also bind at the cell membrane.
- This can trigger a rapid, nongenomic increase in activity of membrane Na⁺–K⁺ exchangers.
- Result described:
- ↑ intracellular Na⁺
- Likely second messenger:
- IP₃ is “probably” involved (not stated as 100% confirmed).
4) MR vs GR receptor “paradox” + the protective enzyme solution
The puzzle
- In vitro, MR has higher affinity for glucocorticoids than the glucocorticoid receptor (GR) does.
- And in vivo, glucocorticoids are present in large amounts.
- So why don’t glucocorticoids occupy MR in kidney and cause mineralocorticoid-like actions?
The key reason (at least partly)
- Mineralocorticoid-sensitive tissues (esp. kidney) have 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2).
What 11β-HSD2 does (selective “shield”)
- Does NOT affect aldosterone (leaves it active/untouched).
- But converts:
- cortisol → cortisone
- corticosterone → its 11-oxy derivative
- These converted forms (11-oxy derivatives) do not bind the MR.
- So MR stays “available” mainly for aldosterone, preventing glucocorticoid “false mineralocorticoid” effects under normal physiology.
5) Other steroids affecting Na⁺ excretion (relative roles)
- Aldosterone: main mineralocorticoid secreted by adrenals.
- Corticosterone:
- secreted in enough quantity to have a minor mineralocorticoid effect.
- Deoxycorticosterone (DOC):
- secreted in appreciable amounts only in abnormal situations
- has about ~3% of aldosterone’s activity.
- Progesterone and some other steroids:
- in large amounts can cause natriuresis (↑ Na⁺ excretion)
- but little evidence they play a normal physiological role in controlling Na⁺ excretion.
6) Effect of adrenalectomy / adrenal insufficiency (what happens when mineralocorticoids are missing)
A) Electrolyte consequences
- Na⁺ is lost in urine (salt wasting).
- K⁺ is retained → plasma K⁺ rises (hyperkalemia tendency).
B) “Rapid onset” insufficiency → Na⁺ shifts into cells too
- When adrenal insufficiency develops rapidly:
- The amount of Na⁺ lost from ECF exceeds the amount excreted in urine
- → implies Na⁺ is also moving into cells (ECF depletion is bigger than urine loss alone can explain).
C) If posterior pituitary intact (ADH intact)
- Salt loss > water loss
- → plasma Na⁺ falls (hyponatremia tendency).
D) Hemodynamic consequences
- Plasma volume decreases
- → hypotension
- → circulatory insufficiency
- → can progress to fatal shock.
E) Salt replacement helps but usually not enough (species note)
- These changes can be partly prevented by ↑ dietary NaCl.
- Rats can survive indefinitely on extra salt alone.
- But in dogs and most humans, the salt requirement is so huge that:
- it’s nearly impossible to prevent eventual collapse/death
- unless mineralocorticoid treatment is also given.
7) Clinical Box — Apparent Mineralocorticoid Excess (AME)
A) Mechanism
- If 11β-HSD2 is absent or inhibited:
- cortisol is no longer inactivated at MR sites
- cortisol gains strong mineralocorticoid effects by acting on MR
- Syndrome name: apparent mineralocorticoid excess (AME).
B) Clinical picture + labs
- Patients look like hyperaldosteronism clinically (because MR is being activated).
- But aldosterone is LOW, because it’s not the driver.
- Plasma renin activity is LOW as well (suppressed).
C) Causes
- Congenital absence of the enzyme can cause AME.
8) Therapeutic highlight — licorice effect (pseudo-hyperaldosteronism)
- Prolonged ingestion of licorice can ↑ blood pressure.
- “Outside the United States,” licorice contains glycyrrhetinic acid.
- Glycyrrhetinic acid inhibits 11β-HSD2.
- So MR is exposed to cortisol → MR-activated Na⁺ absorption increases.
- Mechanism emphasized:
- ↑ sodium absorption via ENaC in the renal collecting duct
- Outcome:
- blood pressure can rise.
Quick exam-logic chain (one-liner)
- Aldosterone → principal cells (CD) → ↑ ENaC function + ↑ ENaC synthesis (SGK early) → ↑ Na⁺ reabsorption → ECF expansion + ↑ K⁺ loss + ↑ H⁺ secretion → acidic urine; MR protected from cortisol by 11β-HSD2; inhibition/absence → AME; licorice (glycyrrhetinic acid) inhibits 11β-HSD2 → ↑ BP.
🟦 MINERALOCORTICOIDS (ALDOSTERONE) — COMPLETE MASTER TABLE (ZERO-OMISSION)
Domain | Aspect | Details (no omissions) |
CORE ACTIONS | Main electrolyte effect | ↑ Na⁺ reabsorption → ↓ Na⁺ excretion |
Sites of Na⁺ conservation | Kidney (urine), sweat, saliva, colon contents | |
Net body effect | Na⁺ retained in ECF → ECF volume expansion | |
Target renal cell | Principal cells (P cells) of collecting ducts | |
Tubular exchange pattern | ↑ Na⁺ reabsorption in exchange for K⁺ and H⁺ | |
Potassium effect | ↑ K⁺ loss in urine → kaliuresis | |
Hydrogen ion effect | ↑ H⁺ secretion → acidic urine | |
--- | --- | --- |
GENOMIC MECHANISM (CLASSIC) | Receptor location | Cytoplasmic mineralocorticoid receptor (MR) |
Nuclear action | Hormone–receptor complex → nucleus → alters gene transcription | |
Time course | Begins 10–30 min, peaks later | |
Why genomic? | Delay implies new protein synthesis required | |
--- | --- | --- |
GENOMIC – EARLY EFFECT | Mechanism | ↑ Insertion of pre-existing ENaCs into apical membrane |
Source of ENaCs | Pre-formed cytoplasmic pool | |
--- | --- | --- |
GENOMIC – LATE EFFECT | Mechanism | ↑ Synthesis of new ENaCs |
Result | Sustained ↑ Na⁺ reabsorption | |
--- | --- | --- |
KEY ALDOSTERONE-INDUCED GENE | Gene | SGK (Serum- and Glucocorticoid-Regulated Kinase) |
Type | Serine–threonine protein kinase | |
Gene timing | Early response gene | |
Functional role | ↑ ENaC activity | |
--- | --- | --- |
ENaC TRANSCRIPTION | Subunits | ↑ mRNAs for all 3 ENaC subunits |
Effect | ↑ channel availability and function | |
--- | --- | --- |
MECHANISTIC NUANCE | Completeness | Aldosterone activates other genes and suppresses some genes |
Conclusion | Full molecular pathway not completely resolved | |
--- | --- | --- |
NONGENOMIC ACTION | Location | Cell membrane binding |
Speed | Rapid, non-transcriptional | |
Effect | ↑ activity of Na⁺–K⁺ exchangers | |
Result | ↑ Intracellular Na⁺ | |
Second messenger | IP₃ probably involved | |
--- | --- | --- |
MR vs GR PARADOX | Problem | MR has higher affinity for glucocorticoids than GR |
Physiologic issue | Glucocorticoids are abundant in plasma | |
--- | --- | --- |
PROTECTIVE SOLUTION | Enzyme | 11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2) |
Tissue | Mineralocorticoid-sensitive tissues (esp. kidney) | |
Action on cortisol | Cortisol → cortisone | |
Action on corticosterone | → 11-oxy derivative | |
Effect on aldosterone | Unaffected | |
MR binding | 11-oxy derivatives cannot bind MR | |
Outcome | MR selectively responds to aldosterone | |
--- | --- | --- |
OTHER STEROIDS & Na⁺ BALANCE | Aldosterone | Primary mineralocorticoid |
Corticosterone | Secreted in enough quantity for minor mineralocorticoid effect | |
Deoxycorticosterone (DOC) | Seen mainly in abnormal states; ~3% aldosterone activity | |
Progesterone & others | Large doses → natriuresis; no major physiologic role | |
--- | --- | --- |
ADRENALECTOMY / INSUFFICIENCY | Urinary effect | ↑ Na⁺ loss, ↓ K⁺ excretion |
Plasma electrolytes | Hyperkalemia tendency | |
Rapid onset feature | Na⁺ loss > urinary loss → Na⁺ shifts into cells | |
ADH intact | Salt loss > water loss → hyponatremia | |
Hemodynamics | ↓ plasma volume → hypotension → shock → death | |
--- | --- | --- |
SALT REPLACEMENT | Partial prevention | ↑ dietary NaCl helps partially |
Species difference | Rats survive on salt alone | |
Humans & dogs | Salt needs too high → mineralocorticoids required | |
--- | --- | --- |
AME (Apparent Mineralocorticoid Excess) | Core defect | ↓ / absent 11β-HSD2 |
Pathophysiology | Cortisol activates MR | |
Clinical picture | Looks like hyperaldosteronism | |
Aldosterone level | Low | |
Plasma renin | Low | |
Cause | Congenital enzyme absence | |
--- | --- | --- |
LICORICE EFFECT | Active compound | Glycyrrhetinic acid |
Source | Licorice (outside USA) | |
Enzyme inhibited | 11β-HSD2 | |
Result | Cortisol → MR activation | |
Renal site | Collecting duct ENaC | |
Outcome | ↑ Na⁺ absorption → ↑ BP |
🧠 ONE-LINE EXAM LOCK
Aldosterone → MR (principal cells) → SGK activation → ↑ ENaC insertion + synthesis → ↑ Na⁺ reabsorption → ECF expansion + ↑ K⁺ loss + ↑ H⁺ secretion → acidic urine; MR protected by 11β-HSD2; loss/inhibition → AME; licorice inhibits 11β-HSD2 → hypertension.
REGULATION OF ALDOSTERONE SECRETION
(Logic-based | zero omission | exam-safe)
1️⃣ CORE CONTROL FRAME (Big Picture)
Aldosterone secretion is regulated by three primary controllers:
- Renin–Angiotensin II system → dominant long-term regulator
- Plasma potassium (K⁺) → most sensitive acute regulator
- ACTH → permissive, transient regulator
📌 Some stimuli increase both aldosterone + glucocorticoids, while others selectively increase aldosterone alone.
2️⃣ STIMULI THAT INCREASE ALDOSTERONE (Complete list)
A) Stimuli that ALSO increase glucocorticoids
- Surgery
- Anxiety
- Physical trauma
- Hemorrhage
👉 Mechanism: ↑ ACTH + ↑ renin
B) Stimuli that DO NOT increase glucocorticoids
- High potassium intake
- Low sodium intake
- Standing (upright posture)
- Constriction of thoracic inferior vena cava
- Secondary hyperaldosteronism (heart failure, cirrhosis, nephrosis)
👉 Mechanism: Renin–angiotensin system ± direct K⁺ effect
3️⃣ EFFECT OF ACTH ON ALDOSTERONE (Subtle but testable)
🔹 Initial effect
- ACTH stimulates aldosterone, glucocorticoids, and sex steroids.
- Aldosterone needs slightly higher ACTH levels than glucocorticoids — but still within physiological range.
🔹 Key exam point: ACTH effect is TRANSIENT
- Aldosterone secretion falls back to baseline within 1–2 days, even if ACTH remains high.
- In contrast:
- Deoxycorticosterone (DOC) remains elevated → ACTH-dependent.
🔹 Why aldosterone falls despite persistent ACTH
- ECF expansion → ↓ renin → ↓ angiotensin II
- Possible ↓ conversion of corticosterone → aldosterone
🔹 After hypophysectomy
- Basal aldosterone = normal
- Stress-induced aldosterone rise = absent
- Salt restriction–induced aldosterone rise = initially preserved
- Long-term → zona glomerulosa atrophy → salt loss + hypoaldosteronism
4️⃣ GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM (GRA) — EXAM FAVORITE
🔹 What goes wrong
- ACTH-stimulated aldosterone secretion loses its transient nature
- Aldosterone hypersecretion → hypertension
🔹 Genetic mechanism (must remember)
- Unequal crossing over on chromosome 8
- 5′ regulatory region of 11β-hydroxylase gene
- Result → ACTH-sensitive aldosterone synthase
fused to coding region of aldosterone synthase
🔹 Clinical logic
- Giving glucocorticoids → suppress ACTH
- ↓ ACTH → ↓ aldosterone → ↓ BP
📌 Autosomal dominant disorder
5️⃣ SECONDARY EFFECTS OF EXCESS MINERALOCORTICOIDS (Escape phenomenon)
A) Electrolyte effects
- K⁺ loss → hypokalemia
- H⁺ loss → metabolic alkalosis
- Na⁺ retention initially
B) Volume & BP effects
- Water retained with Na⁺ → ECF expansion
- Hypertension
- Plasma Na⁺ only mildly ↑ or normal
C) Aldosterone escape
- When ECF expansion exceeds threshold:
- Na⁺ excretion increases despite aldosterone
- Mediated mainly by atrial natriuretic peptide (ANP)
📌 Therefore:
- No edema in normal hyperaldosteronism
- Edema occurs only if escape fails (heart failure, cirrhosis, nephrosis)
6️⃣ EFFECTS OF ANGIOTENSIN II & RENIN (Primary controller)
🔹 Angiotensin II
- Formed from angiotensin I via ACE
- In low doses, selectively ↑ aldosterone
🔹 Sites of action in steroid synthesis
- Early step: Cholesterol → pregnenolone
- Late step: Corticosterone → aldosterone
🚫 Does NOT increase DOC (ACTH-dependent)
🔹 Renin release
- From juxtaglomerular cells
- Triggered by:
- ↓ renal arterial pressure
- ↑ renal sympathetic nerve activity
🔹 Feedback loop
↓ ECF volume → ↑ renin → ↑ angiotensin II → ↑ aldosterone
→ Na⁺ + water retention → ↑ ECF → ↓ renin
🔹 Situations increasing renin → aldosterone
- Hemorrhage
- Standing
- Thoracic IVC constriction
- Low sodium diet
📌 Salt restriction increases renin before BP falls → neural reflex mechanism
🔹 Receptor regulation
- Salt depletion:
- ↑ angiotensin II receptors in adrenal cortex
- ↓ angiotensin II receptors in blood vessels
7️⃣ ELECTROLYTES & OTHER FACTORS
🔹 Sodium
- Acute ↓ Na⁺ ~20 mEq/L → ↑ aldosterone
- Rare in real life
🔹 Potassium (MOST SENSITIVE)
- ↑ K⁺ by only 1 mEq/L → ↑ aldosterone
- Common after K⁺-rich meals
🔹 Mechanism of K⁺ action
- Cell depolarization
- Opening of voltage-gated Ca²⁺ channels
- ↑ intracellular Ca²⁺
- Stimulates:
- Cholesterol → pregnenolone
- DOC → aldosterone
📌 Low K⁺ diet ↓ adrenal sensitivity to angiotensin II
8️⃣ CIRCADIAN & POSTURAL EFFECTS
- Upright posture:
- ↑ renin secretion
- ↓ hepatic clearance of aldosterone
- Bed-rested individuals:
- Circadian rhythm
- Peak aldosterone + renin early morning
🔹 ANP effects
- ↓ renin secretion
- ↓ zona glomerulosa responsiveness to angiotensin II
9️⃣ ROLE OF ALDOSTERONE IN SALT BALANCE (Important nuance)
Aldosterone is NOT the only determinant of Na⁺ excretion.
Other contributors:
- GFR
- ANP
- Osmotic diuresis
- Aldosterone-independent tubular mechanisms
📌 Postural Na⁺ retention occurs too fast to be explained by aldosterone alone.
🎯 Core function of aldosterone system = defense of intravascular volume
🔟 SUMMARY: ADRENOCORTICAL HYPER- & HYPOFUNCTION
🔹 Excess mineralocorticoids (Hyperaldosteronism)
- Hypokalemia
- Hypertension
- Weakness, tetany
- Polyuria
- Metabolic alkalosis
- No edema (unless escape fails)
Primary:
- Conn syndrome (adenoma, hyperplasia, carcinoma)
- GRA
- Renin suppressed
Secondary:
- Heart failure, cirrhosis, nephrosis
- Renin elevated
🔹 Primary adrenal insufficiency (Addison disease)
- Usually autoimmune
- Weight loss, fatigue, hypotension
- Small heart
- Hypoglycemia
- Shock during stress
- Water intoxication risk
- ↑ ACTH → hyperpigmentation
- Salt wasting
- Both mineralocorticoid + glucocorticoid deficiency
🔹 Secondary & tertiary adrenal insufficiency
- ACTH or CRH deficiency
- Milder
- No hyperpigmentation
- Electrolytes relatively preserved
🔹 Special syndromes
- Hyporeninemic hypoaldosteronism
- Pseudohypoaldosteronism
- Aldosterone resistance
- Hyperkalemia
- Salt wasting
- Hypotension
- Metabolic acidosis
🟩 MASTER TABLE SET — REGULATION OF ALDOSTERONE SECRETION
(Logic-based | zero-omission | exam-safe)
🟦 TABLE 1 — PRIMARY REGULATORS (BIG PICTURE)
Regulator | Strength | Time scale | Core role |
Renin–Angiotensin II | ⭐⭐⭐⭐⭐ (dominant) | Long-term | Volume & BP defense |
Plasma K⁺ | ⭐⭐⭐⭐ (most sensitive) | Acute | Protects K⁺ homeostasis |
ACTH | ⭐⭐ (permissive) | Transient | Stress-linked boost |
🟦 TABLE 2 — STIMULI THAT INCREASE ALDOSTERONE
A) Stimuli ↑ Aldosterone AND Glucocorticoids
Stimulus | Pathway |
Surgery | ↑ ACTH + ↑ Renin |
Anxiety | ↑ ACTH + ↑ Renin |
Physical trauma | ↑ ACTH + ↑ Renin |
Hemorrhage | ↑ ACTH + ↑ Renin |
B) Stimuli ↑ Aldosterone ONLY
Stimulus | Mechanism |
High K⁺ intake | Direct zona glomerulosa depolarization |
Low Na⁺ intake | ↑ Renin–Ang II |
Standing | ↑ Renin + ↓ hepatic clearance |
Thoracic IVC constriction | ↓ venous return → ↑ Renin |
Heart failure | Secondary hyperaldosteronism |
Cirrhosis | Secondary hyperaldosteronism |
Nephrosis | Secondary hyperaldosteronism |
🟦 TABLE 3 — ACTH EFFECT (EXAM FAVORITE)
Feature | Aldosterone | DOC |
Initial ACTH response | ↑ | ↑ |
Duration | Transient (1–2 days) | Sustained |
ACTH dependence | Partial | Full |
Reason for fall | ↓ Renin + ↓ Ang II | None |
🟦 TABLE 4 — WHY ALDOSTERONE FALLS DESPITE HIGH ACTH
Mechanism
ECF expansion → ↓ Renin
↓ Angiotensin II
Possible ↓ corticosterone → aldosterone conversion
🟦 TABLE 5 — EFFECT OF HYPOPHYSECTOMY
Situation | Aldosterone |
Basal secretion | Normal |
Stress response | Absent |
Salt restriction (early) | Preserved |
Long-term | Zona glomerulosa atrophy → salt loss |
🟦 TABLE 6 — GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM (GRA)
Feature | Detail |
Inheritance | Autosomal dominant |
Chromosome | 8 |
Defect | Unequal crossing over |
Fusion | 11β-hydroxylase promoter + aldosterone synthase gene |
Result | ACTH-sensitive aldosterone |
Treatment logic | Glucocorticoids ↓ ACTH ↓ Aldosterone ↓ BP |
🟦 TABLE 7 — SECONDARY EFFECTS OF EXCESS MINERALOCORTICOIDS
A) Electrolytes
Effect
Hypokalemia
Metabolic alkalosis
Initial Na⁺ retention
B) Volume & BP
Effect
ECF expansion
Hypertension
Plasma Na⁺ normal / mildly ↑
C) Aldosterone Escape
Feature | Detail |
Trigger | Excess ECF expansion |
Mediator | ANP |
Outcome | ↑ Na⁺ excretion despite aldosterone |
Edema | ❌ unless escape fails |
🟦 TABLE 8 — ANGIOTENSIN II ACTIONS
Feature | Detail |
Dose | Low doses selectively ↑ aldosterone |
Early steroid step | Cholesterol → Pregnenolone |
Late steroid step | Corticosterone → Aldosterone |
DOC effect | ❌ Not increased |
🟦 TABLE 9 — RENIN CONTROL & FEEDBACK
Trigger | Effect |
↓ Renal perfusion | ↑ Renin |
↑ Sympathetic activity | ↑ Renin |
Feedback loop:
↓ ECF → ↑ Renin → ↑ Ang II → ↑ Aldosterone → ↑ ECF → ↓ Renin
🟦 TABLE 10 — SITUATIONS ↑ RENIN → ↑ ALDOSTERONE
Situation
Hemorrhage
Standing
Thoracic IVC constriction
Low sodium diet
📌 Salt restriction ↑ renin before BP falls (neural reflex)
🟦 TABLE 11 — RECEPTOR REGULATION WITH SALT STATUS
Site | Salt depletion |
Adrenal cortex | ↑ Ang II receptors |
Blood vessels | ↓ Ang II receptors |
🟦 TABLE 12 — ELECTROLYTE EFFECTS
Sodium
Feature
Acute ↓ Na⁺ (~20 mEq/L) → ↑ aldosterone
Rare physiologically
Potassium (MOST SENSITIVE)
Feature
↑ K⁺ by
1 mEq/L
→ ↑ aldosterone
Common after meals
🟦 TABLE 13 — MECHANISM OF K⁺ ACTION
Step
Cell depolarization
Opening of voltage-gated Ca²⁺ channels
↑ Intracellular Ca²⁺
↑ Cholesterol → Pregnenolone
↑ DOC → Aldosterone
📌 Low K⁺ diet ↓ adrenal Ang II sensitivity
🟦 TABLE 14 — CIRCADIAN & POSTURAL EFFECTS
Condition | Effect |
Upright posture | ↑ Renin + ↓ aldosterone clearance |
Bed-rest | Circadian rhythm |
Peak time | Early morning |
🟦 TABLE 15 — ANP ACTIONS
Effect
↓ Renin secretion
↓ Zona glomerulosa Ang II responsiveness
🟦 TABLE 16 — ROLE OF ALDOSTERONE IN SALT BALANCE
Contributor to Na⁺ excretion
GFR
ANP
Osmotic diuresis
Aldosterone-independent tubular mechanisms
📌 Postural Na⁺ retention is too fast for aldosterone alone
🎯 Core purpose = intravascular volume defense
🟦 TABLE 17 — HYPER & HYPOALDOSTERONISM SUMMARY
Excess Mineralocorticoids
Feature
Hypokalemia
Hypertension
Weakness
Polyuria
Metabolic alkalosis
No edema (unless escape fails)
Primary Hyperaldosteronism
Cause | Renin |
Conn syndrome | ↓ |
GRA | ↓ |
Secondary Hyperaldosteronism
Cause | Renin |
Heart failure | ↑ |
Cirrhosis | ↑ |
Nephrosis | ↑ |
🟦 TABLE 18 — ADRENAL INSUFFICIENCY
Primary (Addison)
Feature
Autoimmune common
Hypotension
Hypoglycemia
Hyperpigmentation
Salt wasting
Shock risk
Secondary / Tertiary
Feature
ACTH / CRH deficiency
Milder
No hyperpigmentation
Electrolytes preserved
Special Syndromes
Syndrome | Key feature |
Hyporeninemic hypoaldosteronism | ↓ Renin |
Pseudohypoaldosteronism | Aldosterone resistance |
🟦 TABLE 19 — SECOND MESSENGERS (HIGH-YIELD)
Stimulus | Second messenger |
ACTH | cAMP → PKA |
Angiotensin II | DAG → PKC |
K⁺ | Ca²⁺ (voltage-gated channels) |